|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2007-3-16
|
|
pubmed:abstractText |
To test the hypothesis that stroke and systemic embolic events (SEE) in the Stroke Prevention using an ORal Thrombin Inhibitor in atrial Fibrillation (SPORTIF) III and V trials were related to blood pressure, and that differences in event rates (stroke and SEE, bleeding) could also be related to the degree of hypertension.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
0195-668X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
28
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
752-9
|
|
pubmed:meshHeading |
pubmed-meshheading:17289744-Adult,
pubmed-meshheading:17289744-Aged,
pubmed-meshheading:17289744-Anticoagulants,
pubmed-meshheading:17289744-Atrial Fibrillation,
pubmed-meshheading:17289744-Azetidines,
pubmed-meshheading:17289744-Benzylamines,
pubmed-meshheading:17289744-Cross-Sectional Studies,
pubmed-meshheading:17289744-Double-Blind Method,
pubmed-meshheading:17289744-Female,
pubmed-meshheading:17289744-Hemorrhage,
pubmed-meshheading:17289744-Humans,
pubmed-meshheading:17289744-Hypertension,
pubmed-meshheading:17289744-Longitudinal Studies,
pubmed-meshheading:17289744-Male,
pubmed-meshheading:17289744-Middle Aged,
pubmed-meshheading:17289744-Risk Factors,
pubmed-meshheading:17289744-Stroke,
pubmed-meshheading:17289744-Thromboembolism,
pubmed-meshheading:17289744-Warfarin
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
Effect of hypertension on anticoagulated patients with atrial fibrillation.
|
|
pubmed:affiliation |
Haemostasis Thrombosis and Vascular Biology Unit, University Department of Medicine, City Hospital, Birmingham, UK. g.y.h.lip@bham.ac.uk
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Multicenter Study
|
